47
Neonatal Nosocomial Infections Egyptian Data Mohamed Khashaba,MD NCU, MUCH Mansoura Faculty of Medicine Mansoura University, Mansoura, Egypt

Nosocomial Infections in Egypt

Embed Size (px)

Citation preview

Page 1: Nosocomial Infections in Egypt

Neonatal Nosocomial InfectionsEgyptian Data

Mohamed Khashaba,MD

NCU, MUCH

Mansoura Faculty of Medicine

Mansoura University, Mansoura, Egypt

Page 2: Nosocomial Infections in Egypt

Nosocomical Infection

Infections developing in hospitalized patients

and were neither present nor incubating at

time of admission

Page 3: Nosocomial Infections in Egypt

Background

Neonatal deaths constitute about 40% of deaths in children under 5 years

Martines J, et al. Lancet. 2005

Neonatal infections are responsible for approximately one third of the estimated 4.0 million neonatal deaths that occur globally every year

Lawn JE, et al Lancet. 2005.

Page 4: Nosocomial Infections in Egypt

infections may be responsible for 8% to 80% of all neonatal deaths and as many as 42% of deaths in the first week of life.

Rates of neonatal sepsis are as high as

170/1000 live births (clinically diagnosed) and 5.5/1000 live births (blood culture-confirmed).

Page 5: Nosocomial Infections in Egypt

USA Data

The CDC estimates some 90,000 to 100,000 people die from NI each year, and that it costs $4.6 billion per year to treat them. Nosocomial infections are now the fourth leading cause of death in the U.S., right after such other killers as stroke, cancer and heart disease.

Page 6: Nosocomial Infections in Egypt

Hospital-based data suggest alarming rates of resistance to ampicillin and gentamicin, the first-line antimicrobial agents

Durrane et al: Pediatric Infectious Disease Journal 28 (1):s19-s21,2009

Page 7: Nosocomial Infections in Egypt

71% of Klebsiella and 50% of Escherichia coli are reportedly resistant to gentamicin,

TOSHIBA
TOSHIBA
suggesting that the who recommended amp, gent combination for ttt of neonatal sepsis may not be longer effective.
Page 8: Nosocomial Infections in Egypt

The challenge for medicine is to attempt to treat disease with as minimal disruption to the patient’s physiology and normal host flora as possible.

Page 9: Nosocomial Infections in Egypt

Objectives

1. Factors contributing to Nosocomial Infection in Egyptian Nurseries

2. Egyptian published Data.

3. MUCH, NCU Data of 2008.

Page 10: Nosocomial Infections in Egypt

Objectives

1. Factors contributing to Nosocomial Infection in Egyptian Nurseries

2. Egyptian published Data.

3. MUCH, NCU Data of 2008.

Page 11: Nosocomial Infections in Egypt

.Factors contributing to nosocomial infections in Egypt

Overcrowding and understaffing

Abuse of antibiotics and other drugs

Non compliance to infection control policy.

Lack of facilities for diagnosis and surveillance.

Page 12: Nosocomial Infections in Egypt

Overcrowding and understaffing

Nurse : patient ratio.

Space and allocation

Page 13: Nosocomial Infections in Egypt

Abuse of antibiotics

Cephalosporines as 1st line empirical antibiotic.

Other drugs e.g. H2 blockers

Page 14: Nosocomial Infections in Egypt

Non compliance to infection control policy

Hand washing.

Drying hands.

Reusable instruments.

Parenteral Nutrition and fluids

Page 15: Nosocomial Infections in Egypt

Lack of facilities for diagnosis and surveillance

lack of appropriate culture and susceptibility testing facilities and challenges of conducting studies.

Page 16: Nosocomial Infections in Egypt

Objectives

1. Factors contributing to Nosocomial Infection in Egyptian Nurseries

2. Egyptian published Data.

3. MUCH, NCU Data of 2008.

Page 17: Nosocomial Infections in Egypt

el-Teheawy et al. in Egypt in 1988 reported that >80% of admitted patients were prescribed antibiotics, in many cases without documented proof of infection.

Among these patients, >30% received repeated courses, with no apparent indication.

Page 18: Nosocomial Infections in Egypt

J Egypt Public Health Assoc. 1990;65:207–220.

Mohamed TA.

Registration of births and infants deaths in Demo village in Fayoum governorate.

Mansour

E,

Eissa

AN,

Nofal

LM

,

et

al.

Morbidity

andeightinfants in

Egypt.

East

Mediterr

Health

J.

2005;11:723–731

Page 19: Nosocomial Infections in Egypt

Journal of Tropical Pediatrics 1996 42(3):154-157

Maternal and Neonatal Prevalence of Toxoplasma and Cytomegalovirus (CMV) Antibodies and Hepatitis-B Antigens in an Egyptian Rural Area

,Ahmed El-Nawawy, Ashraf T. Soliman,, Omar El Azzouni,, El-Sayed Amer,, Mohammed Abdel Karim,, Soheir Demian, MonEl Sayed,

Page 20: Nosocomial Infections in Egypt

Journal of Women's Health

Effect of Predelivery Vaginal Antisepsis on Maternal and Neonatal Morbidity and Mortality in Egypt

Ahmad F. Bakr,

Department of Pediatric ,Alexandria University, Egypt.

Page 21: Nosocomial Infections in Egypt

Journal of Antimicrobial Chemotherapy (2003) 51, 625–630

Antimicrobial resistance in Cairo, Egypt 1999–2000: a survey of five hospitals.

Amani El Kholy1, Hadia Baseem2, Geraldine S. Hall3*, Gary W. Procop3 and David L. Longworth4

Page 22: Nosocomial Infections in Egypt

Antimicrobial resistance

10 relevant reports were retrievedE. coli were ampicillin (72%) and cotrimoxazole%) resistant;

19% were resistant to third generation cephalosporins.

Klebsiella species, almost all were resistant to ampicillin, , and 66% to third generation cephalosporins. Resistance to gentamicin was low among E. coli (13%), but

much higher among Klebsiella species (60%). Methicillin resistance S. aureus (MRSA) was rare (1 of 33isolates) but 46% were resistant to cotrimoxazole

Page 23: Nosocomial Infections in Egypt

They suggested a potentially high rate of extended-spectrum β-lactamase (ESBL)

Page 24: Nosocomial Infections in Egypt

The Pediatric Infectious Disease Journal: 23(8)August 2004pp 719-725

Topically Applied Sunflower Seed Oil Prevents Invasive Bacterial Infections in Preterm Infants in Egypt: A Randomized, Controlled Clinical Trial

Darmstadt, Gary L. Badrawi, Nadia Law, Paul A.; Ahmed, Saifuddin Bashir, Moataza ,Iskander, Iman Said, Dalia Al Kholy, Amani El Husein, Mohamed Hassan Alam, Asif Winch, Peter J., Gipson, Reginald Santosham, Muhammad

Page 25: Nosocomial Infections in Egypt

Health JournalRegional Office WHO EMRO

Volume 11 No 4 May , 2005 

Morbidity and mortality of low-birth-weight infants in Egypt

E. Mansour,1 A.N. Eissa,2 L.M. Nofal,3 I. Kharboush3 and A.A. Reda3

Page 26: Nosocomial Infections in Egypt

Med Princ Pract 2008;17:500-503

Case ReportPantoea agglomerans Bloodstream Infection in Preterm

NeonatesNasser Yehia A. Alya, b, Hadeel N. Salmeene, Reda A. Abo Lilac, Prem A. Nagarajad

Department of Tropical Medicine and Hygiene, Faculty of Medicine, University of Alexandria, Alexandria, Egypt; Departments of Neonatology, infection control,

Page 27: Nosocomial Infections in Egypt

Fives cases of nosocomial BSI with P. agglomerans in preterm neonates (weight 1,500 g; age 8-17 days; gestational age 26-30 weeks

All isolates shared in vitro susceptibility to gentamicin, amikacin, ciprofloxacin, piperacillin/tazobactam and meropenem

Page 28: Nosocomial Infections in Egypt

Journal of Perinatology (2008) 28, 685–690

Extended-spectrum -lactamase producing Klebsiella pneumoniae in neonatal intensive care unit

H Abdel-Hady1, S Hawas2, M El-Daker2 and R El-Kady2

Page 29: Nosocomial Infections in Egypt

Our results call for further epidemiological studies to define whether ESBLs are highly endemic in the community.

Page 30: Nosocomial Infections in Egypt

Objectives

1. Factors contributing to Nosocomial Infection in Egyptian Nurseries

2. Egyptian published Data.

3. MUCH, NCU Data of 2008.

Page 31: Nosocomial Infections in Egypt

NCI RATE BY MONTH

1 2 . 81 0 . 7

1 3 . 7

1 6 . 9

1 4

5 . 9

9 . 4

1 4 . 5

2 6 . 9

5 . 4

1 0 . 9

1 9 . 2

0

5

1 0

1 5

2 0

2 5

3 0

M O N T H

NC

I R

AT

E

Page 32: Nosocomial Infections in Egypt

 

Duration of

Hospital Stay

Admis.Age

Gest. ageAdmisn.

wt

Mean32.47.234.72.1

Median284371.97

Std deviation21.67.74.80.8

Max8132173.26

Minimum31230.74

Range8433404

Page 33: Nosocomial Infections in Egypt

Gestational Age

3 1 %

6 %

1 1 %

5 2 %

= < 3 2 w k

3 2 - < 3 4

3 4 - < 3 7 w k

= > 3 7 w k

Page 34: Nosocomial Infections in Egypt

GENDER

4 1 ; 4 8 %4 4 ;

5 2 %

M a l eF e m a l e

Page 35: Nosocomial Infections in Egypt

Admission Age

1 0 ; 1 2 %

4 1 ; 4 8 %

3 4 ; 4 0 % 1 s t d a y

2 - < 7 d a y s

= > 7 d a y s

Page 36: Nosocomial Infections in Egypt

Site of Born

1 3 ; 1 5 %

7 2 ; 8 5 %

In b o r n

O u t b o r n

Page 37: Nosocomial Infections in Egypt

Type of Delivery

3 7 ; 4 4 %

4 8 ; 5 6 %

S V D

C S

Page 38: Nosocomial Infections in Egypt

3 5

6 0

1 7

4 3

7 9

5 0

2 5

6 8

4 2

6

01 02 03 04 05 06 07 08 09 0

Sur

gery

Intu

batio

n

Cen

tral l

ine

Con

geni

tal

mal

form

antio

n TPN

P o s t i v e

N e g a t i v e

Page 39: Nosocomial Infections in Egypt

Infection Form

6 3

2 1

6

3

0 2 0 4 0 6 0 8 0

B lo o d s t r e a m in f e c t io n

L R T I

W o u n d in f e c t io n

U T I

Page 40: Nosocomial Infections in Egypt

I S O L A T E D O R G A N I S M S

4 2 %

1 5 %

1 3 %

7 %

6 %

5 %

3 %3 %

2 % 1 %1 %1 %1 %

K le b s ie lla s p e c ie s

S t a p h y lo c o c c u s a u r e u s

M R S A

C a n d id a

P r o t e u s s p e c ie s

P s e u d o m o n a s S p e c ie s

C o N S

E . c o li

E n t e r o c o c c i

S t r e p t o c o c c u s p y o g e n e s

B a c illu s c e r e u s

C it r o b a c t e r

A c in t o b a c t e r S p e c ie s .

Page 41: Nosocomial Infections in Egypt

Antibiotic Susceptibility pattern1 0 0

0

8 1 . 1

1 9 . 9

7 1 . 4

2 8 . 6

6 2

3 8

5 9 . 1

4 0 . 9

0

2 0

4 0

6 0

8 0

1 0 0

Va

nc

om

yc

in

Ta

zo

cin

Me

rop

en

em

Ime

pe

ne

m

Am

ika

cin

S

R

Page 42: Nosocomial Infections in Egypt

Our results call for implementation of a regional and nationwide surveillance system to monitor antimicrobial resistance trends in Egypt

Page 43: Nosocomial Infections in Egypt

Addressed Questions

1.What is the feasibility and effectiveness of approaches to improve aseptic practices in labor rooms, maternity pediatric wards and nurseries?

2. What is the feasibility and effectiveness of approaches to increase quality of care in hospitals, such as using standardized protocols for management of infections in hospitals?

Page 44: Nosocomial Infections in Egypt

Research priorities Other Than Health Policy and Systems Research

Identification of new interventions to prevent transmission of infections during childbirth, eg, chlorhexidine vaginal douche, immune modulators like zinc to mothers.

Epidemiology What is the incidence of

nosocomial neonatal sepsis in nurseries and postnatal wards of developing countries?

Page 45: Nosocomial Infections in Egypt

Two recent factors influencing infection control are:

use of antibiotic-bonded vascular catheters and access to alcohol hand-cleansing materials that improve handwashing compliance

D Thornby et al 1999

Page 46: Nosocomial Infections in Egypt

Change of technology or Behaviour?

the former will likely be 5 to 10 times more effective, but at substantially increased cost. Neither, however, is mutually exclusive, and both need to be in place.

  

Page 47: Nosocomial Infections in Egypt